IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

LOS ANGELES -- Cardiac surgeons were urged to readjust their attitudes toward the tricuspid valve if they want to keep some footing in a rapidly evolving field dominated by transcatheter innovations.

People with tricuspid regurgitation (TR) are heavily reliant on care from their adult children and generally would like more and earlier education about their condition—these are the messages that ...

A new device for relieving tricuspid valve regurgitation has concluded clinical trials, with researchers reporting increased quality-of-life surveys, reduced disease severity results, and safe patient ...

PARIS, France—Percutaneous edge-to-edge repair with a clip device appears to offer some hope for patients with tricuspid regurgitation, according to new results from the TRILUMINATE study. At 30 days, ...

LONG BEACH, Calif., June 4, 2025 /PRNewswire/ -- The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., ...

PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Atrium Health Sanger Heart & Vascular Institute has ...

Cory and Taylor’s newborn daughter Maya was diagnosed with Tricuspid Atresia. Pic credit: @taylor.selfridge/Instagram Teen Mom OG couple Cory Wharton and Taylor Selfridge’s newborn daughter Maya Grace ...

An international study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) and also have less than severe ...